;PMID: 9855271
;source_file_1380.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..43] = [t:0..43]
;1)sentence:[e:48..166] = [t:48..166]
;2)section:[e:170..272] = [t:170..272]
;3)section:[e:276..358] = [t:276..358]
;4)sentence:[e:362..441] = [t:362..441]
;5)sentence:[e:443..619] = [t:443..619]
;6)sentence:[e:620..788] = [t:620..788]
;7)sentence:[e:789..931] = [t:789..931]
;8)sentence:[e:932..1088] = [t:932..1088]
;9)sentence:[e:1089..1195] = [t:1089..1195]
;10)sentence:[e:1196..1286] = [t:1196..1286]
;11)sentence:[e:1287..1400] = [t:1287..1400]
;12)sentence:[e:1401..1502] = [t:1401..1502]
;13)section:[e:1506..1550] = [t:1506..1550]

;section 0 Span:0..43
;J Clin Gastroenterol  1998 Dec;27(4):357-60
(SEC
  (FRAG (NNP:[0..1] J) (DT:[2..6] Clin) (NNP:[7..20] Gastroenterol)
        (CD:[22..26] 1998) (.:[27..34] Dec;27-LRB-) (CD:[34..36] 4-RRB-)
        (CD:[36..40] :357) (HYPH:[40..41] -) (CD:[41..43] 60)))

;sentence 1 Span:48..166
;Pancreatic cancer associated with granulocyte-colony stimulating factor 
;production confirmed by immunohistochemistry.
;[48..65]:malignancy:"Pancreatic cancer"
;[82..119]:gene-protein:"granulocyte-colony stimulating factor"
(SENT
  (NP-HLN
    (NP
      (NP (JJ:[48..58] Pancreatic) (NN:[59..65] cancer))
      (VP (VBN:[66..76] associated)
        (NP (-NONE-:[76..76] *))
        (PP-CLR (IN:[77..81] with)
          (NP
            (NML
              (NML
                (NML (NN:[82..93] granulocyte) (HYPH:[93..94] -)
                     (NN:[94..100] colony))
                (VBG:[101..112] stimulating))
              (NN:[113..119] factor))
            (NN:[121..131] production)))))
    (VP (VBN:[132..141] confirmed)
      (NP (-NONE-:[141..141] *))
      (PP-MNR (IN:[142..144] by)
        (NP (NN:[145..165] immunohistochemistry))))
    (.:[165..166] .)))

;section 2 Span:170..272
;Ohtsubo K, Mouri H, Sakai J, Akasofu M, Yamaguchi Y, Watanabe H, Gabata T,
;Motoo  Y, Okai T, Sawabu N.
(SEC
  (FRAG (NNP:[170..177] Ohtsubo) (NNP:[178..179] K) (,:[179..180] ,)
        (NNP:[181..186] Mouri) (NNP:[187..188] H) (,:[188..189] ,)
        (NNP:[190..195] Sakai) (NNP:[196..198] J,) (NNP:[199..206] Akasofu)
        (NNP:[207..209] M,) (NNP:[210..219] Yamaguchi) (NNP:[220..221] Y)
        (,:[221..222] ,) (NNP:[223..231] Watanabe) (NNP:[232..233] H)
        (VBD:[233..234] ,) (NNP:[235..241] Gabata) (NNP:[242..243] T)
        (,:[243..244] ,) (NNP:[245..250] Motoo) (NNP:[252..253] Y)
        (VBD:[253..254] ,) (NNP:[255..259] Okai) (NNP:[260..261] T)
        (,:[261..262] ,) (NNP:[263..269] Sawabu) (NNP:[270..272] N.)))

;section 3 Span:276..358
;Department of Internal Medicine and Medical Oncology, Kanazawa University, 
;Japan.
(SEC
  (FRAG (NNP:[276..286] Department) (IN:[287..289] of) (NNP:[290..298] Internal)
        (NNP:[299..307] Medicine) (CC:[308..311] and) (NNP:[312..319] Medical)
        (NNP:[320..328] Oncology) (,:[328..329] ,) (NNP:[330..338] Kanazawa)
        (NNP:[339..349] University) (,:[349..350] ,) (NNP:[352..357] Japan)
        (.:[357..358] .)))

;sentence 4 Span:362..441
;We report an 83-year-old man with pancreatic body cancer of 4.5 cm in
;diameter.
;[396..440]:malignancy:"pancreatic body cancer of 4.5 cm in diameter"
(SENT
  (S
    (NP-SBJ (PRP:[362..364] We))
    (VP (VBP:[365..371] report)
      (NP
        (NP (DT:[372..374] an)
          (ADJP
            (NML (CD:[375..377] 83) (HYPH:[377..378] -) (NN:[378..382] year))
            (HYPH:[382..383] -) (JJ:[383..386] old))
          (NN:[387..390] man))
        (PP (IN:[391..395] with)
          (NP
            (NP (JJ:[396..406] pancreatic) (NN:[407..411] body)
                (NN:[412..418] cancer))
            (PP (IN:[419..421] of)
              (NP
                (NP (CD:[422..425] 4.5) (NN:[426..428] cm))
                (PP (IN:[429..431] in)
                  (NP (NN:[432..440] diameter)))))))))
    (.:[440..441] .)))

;sentence 5 Span:443..619
;Peripheral leukocyte count was 15,700/microl and the serum concentration of 
;granulocyte-colony stimulating factor (G-CSF) was 123 pg/ml (normal, 6.0-21.9
; pg/ml) on admission.
;[520..557]:gene-protein:"granulocyte-colony stimulating factor"
;[559..564]:gene-protein:"G-CSF"
(SENT
  (S
    (S
      (NP-SBJ (JJ:[443..453] Peripheral) (NN:[454..463] leukocyte)
              (NN:[464..469] count))
      (VP (VBD:[470..473] was)
        (NP-PRD
          (NP (CD:[474..480] 15,700))
          (PP (SYM:[480..481] /)
            (NP (NN:[481..487] microl))))))
    (CC:[488..491] and)
    (S
      (NP-SBJ
        (NP (DT:[492..495] the) (NN:[496..501] serum)
            (NN:[502..515] concentration))
        (PP (IN:[516..518] of)
          (NP
            (NP
              (NML
                (NML (NN:[520..531] granulocyte) (HYPH:[531..532] -)
                     (NN:[532..538] colony))
                (VBG:[539..550] stimulating))
              (NN:[551..557] factor))
            (NP (-LRB-:[558..559] -LRB-) (NN:[559..564] G-CSF)
                (-RRB-:[564..565] -RRB-)))))
      (VP (VBD:[566..569] was)
        (NP-PRD
          (NP (CD:[570..573] 123) (NN:[574..576] pg))
          (PP (SYM:[576..577] /)
            (NP (NN:[577..579] ml))))
        (PRN (-LRB-:[580..581] -LRB-)
          (S
            (NP-SBJ (JJ:[581..587] normal))
            (,:[587..588] ,)
            (NP-PRD
              (NP
                (QP (CD:[589..592] 6.0) (HYPH:[592..593] -) (CD:[593..597] 21.9))
                (NN:[599..601] pg))
              (PP (SYM:[601..602] /)
                (NP (NN:[602..604] ml)))))
          (-RRB-:[604..605] -RRB-))
        (PP (IN:[606..608] on)
          (NP (NN:[609..618] admission)))))
    (.:[618..619] .)))

;sentence 6 Span:620..788
;Furthermore, not only K-ras codon 12 (GGT --> GAT) but also  p53 at codon 247
;(CGG --> CCG) mutations were identified in the pancreatic juice  aspirated
;endoscopically.
;[642..647]:gene-rna:"K-ras"
;[648..656]:variation-location:"codon 12"
;[658..661]:variation-state-original:"GGT"
;[666..669]:variation-state-altered:"GAT"
;[681..684]:gene-rna:"p53"
;[688..697]:variation-location:"codon 247"
;[699..702]:variation-state-original:"CGG"
;[707..710]:variation-state-altered:"CCG"
;[712..721]:variation-event:"mutations"
(SENT
  (S
    (ADVP (RB:[620..631] Furthermore))
    (,:[631..632] ,)
    (NP-SBJ-2
      (CONJP (RB:[633..636] not) (RB:[637..641] only))
      (NP (NN:[642..647] K-ras)
        (NML (NN:[648..653] codon) (CD:[654..656] 12))
        (NML-1 (-NONE-:[656..656] *P*))
        (PRN (-LRB-:[657..658] -LRB-)
          (NP
            (NP (NN:[658..661] GGT))
            (PP (SYM:[662..665] -->)
              (NP (NN:[666..669] GAT))))
          (-RRB-:[669..670] -RRB-)))
      (CONJP (CC:[671..674] but) (RB:[675..679] also))
      (NP
        (NP (NN:[681..684] p53))
        (PP-LOC (IN:[685..687] at)
          (NP
            (NML (NN:[688..693] codon) (CD:[694..697] 247))
            (PRN (-LRB-:[698..699] -LRB-)
              (NP
                (NP (NN:[699..702] CGG))
                (PP (SYM:[703..706] -->)
                  (NP (NN:[707..710] CCG))))
              (-RRB-:[710..711] -RRB-))
            (NML-1 (NNS:[712..721] mutations))))))
    (VP (VBD:[722..726] were)
      (VP (VBN:[727..737] identified)
        (NP-2 (-NONE-:[737..737] *))
        (PP-LOC (IN:[738..740] in)
          (NP
            (NP (DT:[741..744] the) (JJ:[745..755] pancreatic)
                (NN:[756..761] juice))
            (VP (VBN:[763..772] aspirated)
              (NP (-NONE-:[772..772] *))
              (ADVP-MNR (RB:[773..787] endoscopically)))))))
    (.:[787..788] .)))

;sentence 7 Span:789..931
;We performed chemotherapy with two courses of  5-fluorouracil, pirarubicin
;hydrochloride, and mitomycin-C, resulting in no  beneficial effect.
(SENT
  (S
    (NP-SBJ (PRP:[789..791] We))
    (VP (VBD:[792..801] performed)
      (NP (NN:[802..814] chemotherapy))
      (PP-MNR (IN:[815..819] with)
        (NP
          (NP (CD:[820..823] two) (NNS:[824..831] courses))
          (PP (IN:[832..834] of)
            (NP
              (NP (NN:[836..850] 5-fluorouracil))
              (,:[850..851] ,)
              (NP (NN:[852..863] pirarubicin) (NN:[864..877] hydrochloride))
              (,:[877..878] ,) (CC:[879..882] and)
              (NP (NN:[883..894] mitomycin-C))))))
      (,:[894..895] ,)
      (S-ADV
        (NP-SBJ (-NONE-:[895..895] *))
        (VP (VBG:[896..905] resulting)
          (PP-CLR (IN:[906..908] in)
            (NP (DT:[909..911] no) (JJ:[913..923] beneficial)
                (NN:[924..930] effect))))))
    (.:[930..931] .)))

;sentence 8 Span:932..1088
;After the second course the patient developed interstitial  pneumonia,
;probably caused by anticancer drugs, and died 4 months after the  tumor was
;detected.
;[1069..1074]:malignancy:"tumor"
(SENT
  (S
    (PP-TMP (IN:[932..937] After)
      (NP (DT:[938..941] the) (JJ:[942..948] second) (NN:[949..955] course)))
    (NP-SBJ (DT:[956..959] the) (NN:[960..967] patient))
    (VP
      (VP (VBD:[968..977] developed)
        (NP
          (NP (JJ:[978..990] interstitial) (NN:[992..1001] pneumonia))
          (,:[1001..1002] ,)
          (VP
            (ADVP (RB:[1003..1011] probably))
            (VBN:[1012..1018] caused)
            (NP (-NONE-:[1018..1018] *))
            (PP (IN:[1019..1021] by)
              (NP-LGS (JJ:[1022..1032] anticancer) (NNS:[1033..1038] drugs))))))
      (,:[1038..1039] ,) (CC:[1040..1043] and)
      (VP (VBD:[1044..1048] died)
        (NP-TMP
          (NP (CD:[1049..1050] 4) (NNS:[1051..1057] months))
          (PP (IN:[1058..1063] after)
            (S-NOM
              (NP-SBJ-1 (DT:[1064..1067] the) (NN:[1069..1074] tumor))
              (VP (VBD:[1075..1078] was)
                (VP (VBN:[1079..1087] detected)
                  (NP-1 (-NONE-:[1087..1087] *)))))))))
    (.:[1087..1088] .)))

;sentence 9 Span:1089..1195
;In the autopsy tissue, the tumor macroscopically occupied  the pancreas body
;and was 7 x 6 x 5 cm in size.
;[1116..1121]:malignancy:"tumor"
(SENT
  (S
    (PP-LOC (IN:[1089..1091] In)
      (NP (DT:[1092..1095] the) (NN:[1096..1103] autopsy)
          (NN:[1104..1110] tissue)))
    (,:[1110..1111] ,)
    (NP-SBJ (DT:[1112..1115] the) (NN:[1116..1121] tumor))
    (VP
      (VP
        (ADVP (RB:[1122..1137] macroscopically))
        (VBD:[1138..1146] occupied)
        (NP (DT:[1148..1151] the) (NN:[1152..1160] pancreas)
            (NN:[1161..1165] body)))
      (CC:[1166..1169] and)
      (VP (VBD:[1170..1173] was)
        (NP-PRD
          (NP
            (QP (CD:[1174..1175] 7) (SYM:[1176..1177] x) (CD:[1178..1179] 6)
                (SYM:[1180..1181] x) (CD:[1182..1183] 5))
            (NN:[1184..1186] cm))
          (PP (IN:[1187..1189] in)
            (NP (NN:[1190..1194] size))))))
    (.:[1194..1195] .)))

;sentence 10 Span:1196..1286
;Histopathologic diagnosis of the  tumor was poorly differentiated
;adenosquamous carcinoma.
;[1230..1235]:malignancy:"tumor"
;[1240..1285]:malignancy:"poorly differentiated adenosquamous carcinoma"
(SENT
  (S
    (NP-SBJ
      (NP (JJ:[1196..1211] Histopathologic) (NN:[1212..1221] diagnosis))
      (PP (IN:[1222..1224] of)
        (NP (DT:[1225..1228] the) (NN:[1230..1235] tumor))))
    (VP (VBD:[1236..1239] was)
      (NP-PRD
        (ADJP (RB:[1240..1246] poorly) (VBN:[1247..1261] differentiated))
        (JJ:[1262..1275] adenosquamous) (NN:[1276..1285] carcinoma)))
    (.:[1285..1286] .)))

;sentence 11 Span:1287..1400
;Immunohistochemical  staining of the autopsy tissue showed that pancreatic
;cancer cells were positive  for G-CSF.
;[1351..1368]:malignancy:"pancreatic cancer"
;[1394..1399]:gene-protein:"G-CSF"
(SENT
  (S
    (NP-SBJ
      (NP (JJ:[1287..1306] Immunohistochemical) (NN:[1308..1316] staining))
      (PP (IN:[1317..1319] of)
        (NP (DT:[1320..1323] the) (NN:[1324..1331] autopsy)
            (NN:[1332..1338] tissue))))
    (VP (VBD:[1339..1345] showed)
      (SBAR (IN:[1346..1350] that)
        (S
          (NP-SBJ
             (JJ:[1351..1361] pancreatic) (NN:[1362..1368] cancer)
            (NNS:[1369..1374] cells))
          (VP (VBD:[1375..1379] were)
            (ADJP-PRD (JJ:[1380..1388] positive)
              (PP (IN:[1390..1393] for)
                (NP (NN:[1394..1399] G-CSF))))))))
    (.:[1399..1400] .)))

;sentence 12 Span:1401..1502
;This is the first case report of G-CSF-positive pancreatic cancer  confirmed
;by immunohistochemistry.
;[1434..1466]:malignancy:"G-CSF-positive pancreatic cancer"
;[1434..1439]:gene-protein:"G-CSF"
(SENT
  (S
    (NP-SBJ (DT:[1401..1405] This))
    (VP (VBZ:[1406..1408] is)
      (NP-PRD
        (NP (DT:[1409..1412] the) (JJ:[1413..1418] first) (NN:[1419..1423] case)
            (NN:[1424..1430] report))
        (PP (IN:[1431..1433] of)
          (NP
            (NP
              (NML (NN:[1434..1439] G-CSF) (HYPH:[1439..1440] -)
                   (JJ:[1440..1448] positive))
              (JJ:[1449..1459] pancreatic) (NN:[1460..1466] cancer))
            (VP (VBN:[1468..1477] confirmed)
              (NP (-NONE-:[1477..1477] *))
              (PP (IN:[1478..1480] by)
                (NP (NN:[1481..1501] immunohistochemistry))))))))
    (.:[1501..1502] .)))

;section 13 Span:1506..1550
;PMID: 9855271 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1506..1510] PMID) (::[1510..1511] :) (CD:[1512..1519] 9855271)
        (IN:[1520..1521] -LSB-) (NNP:[1521..1527] PubMed) (HYPH:[1528..1529] -)
        (JJ:[1530..1537] indexed) (IN:[1538..1541] for)
        (NNP:[1542..1550] MEDLINE-RSB-)))
